164 related articles for article (PubMed ID: 1386567)
21. [Comparison of new cardiac agents using differential therapeutic criteria].
Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
[TBL] [Abstract][Full Text] [Related]
22. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
[TBL] [Abstract][Full Text] [Related]
23. [Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
Boldt J; Kling D; Schuhmann E; Dapper F; Hempelmann G
Anaesthesist; 1989 May; 38(5):238-44. PubMed ID: 2525351
[TBL] [Abstract][Full Text] [Related]
24. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
[TBL] [Abstract][Full Text] [Related]
25. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
[TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.
Smith NA; Kates RE; Lebsack C; Ruder MA; Mead RH; Bekele T; Okerholm RA; Rubin GM; Winkle RA
Am Heart J; 1991 Sep; 122(3 Pt 1):755-63. PubMed ID: 1831585
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.
Gilbert EM; Hershberger RE; Wiechmann RJ; Movsesian MA; Bristow MR
Chest; 1995 Dec; 108(6):1524-32. PubMed ID: 7497755
[TBL] [Abstract][Full Text] [Related]
29. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
[TBL] [Abstract][Full Text] [Related]
30. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
[TBL] [Abstract][Full Text] [Related]
31. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
[TBL] [Abstract][Full Text] [Related]
32. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B
Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004
[TBL] [Abstract][Full Text] [Related]
33. [Long-term therapy of chronic cardiac insufficiency using enoximone].
Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
[TBL] [Abstract][Full Text] [Related]
34. Enoximone, a post-operative inodilator in patients following mitral valve operation: a prospective and controlled study.
Hausen B; von der Leyen H; Vogelpohl J; Dresler C; Heublein B; Haverich A
Eur Heart J; 1992 May; 13(5):679-86. PubMed ID: 1535588
[TBL] [Abstract][Full Text] [Related]
35. Acute effects of enoximone in chronic heart failure.
Saborowski F; Peters P; Schneider M; Fehske W; Dieterich HA
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S57-61. PubMed ID: 2480487
[TBL] [Abstract][Full Text] [Related]
36. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
Leier CV; Meiler SE; Matthews S; Unverferth DV
Am J Cardiol; 1987 Aug; 60(5):27C-30C. PubMed ID: 2956864
[TBL] [Abstract][Full Text] [Related]
37. Acute hemodynamic response to intravenous enoximone: an animal study and preliminary report in infants after cardiac surgery.
Schranz D; Huth R; Dahm M; Iversen S; Hein E; Stopfkuchen H; Jüngst BK
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S62-8. PubMed ID: 2480488
[TBL] [Abstract][Full Text] [Related]
38. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
39. [Enoximone as pharmacologic "bridging" to heart transplantation].
Friedel N; Teebken M; Lemme A; Schüler S; Hetzer R
Z Kardiol; 1991; 80 Suppl 4():27-33. PubMed ID: 1833894
[TBL] [Abstract][Full Text] [Related]
40. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
Leier CV; Lima JJ; Meiler SE; Unverferth DV
Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
